% | $
Quotes you view appear here for quick access.

Novavax, Inc. Message Board

  • mistersir2005 mistersir2005 Apr 16, 2013 12:12 PM Flag


    Funny ....the move up today happened at the same time John Boslego, of the Global Program Leader, Vaccine Development at PATH was speaking about "Driving development of much needed vaccines for the developing world" the World Vaccine Conference....

    next up....Tom Monath...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Truth be told, I never banked a strategy where I'm profitting from a pandemic flu outbreak. I started invested in Novavax after they received the BARDA contract which is 1-2 years ago, and I accumulated steady throughout time. So my cost basis is quite low and I have a sizeable position, and I always thought this company could save lives because the technology fits an unmet need. I thought NVAX would be a first responder to pandemic flu, and the star of the pipeline was RSV. I initially invested in Novavax because of the BARDA contract, but invested heavily because of RSV.

      The next share price driver will be Elderly RSV phase I top line, and hopefully PATH partnership extension. We know the flu vaccine works and how quickly it can be made because actual vaccines were administered to Mexicans in the 2009 swine flu outbreak. That gave me confidence in the technology. And with Protein Sciences vaccine using VLP tech approved by FDA, I think the regulatory pathway becomes even smoother as more patient data is collected.

      Bird flu may come and go. I actually hope it stays contained in China and stays non-H2H transmission. I feel good at night knowing that if there is an outbreak, I invested in a first responder that may save many many lives.

    • or it could be the panel from Sanofi and Novartis speaking about..."What are Big Pharma Business Development Heads looking for in partnerships?"

    • thanks for the update......are you at the Conference?

      Sentiment: Strong Buy

2.08+0.020(+0.97%)Sep 30 4:00 PMEDT